Calidi Biotherapeutics (CLDI) Institutional Ownership $0.83 -0.06 (-6.63%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Calidi Biotherapeutics (NYSE:CLDI)CurrentInstitutional OwnershipPercentage12.53%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$51.75KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$659.08K Get CLDI Insider Trade Alerts Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLDI Institutional Buying and Selling by Quarter Calidi Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/14/2025 CPR Investments Inc.101,000$116K0.1%+80.4%0.772% 11/15/2024Red Wave Investments LLC46,461$53K0.0%-92.6%0.418% 8/15/2024Delta Investment Management LLC210,230$42K0.0%+1,955.0%0.413% 8/8/2024RS Crum Inc.263,470$53K0.0%+2,327.4%0.517% 7/19/2024 CPR Investments Inc.560,000$112K0.1%+700.0%11.002% 5/16/2024Apollo Management Holdings L.P.125,000$71K0.0%N/A0.352% 5/15/2024Magnetar Financial LLC63,132$36K0.0%N/A0.178% 5/14/2024Evermay Wealth Management LLC63,416$36K0.0%N/A0.178% 4/23/2024Spectrum Asset Management Inc. NB CA 166,494$94K0.0%N/A0.468% (Data available from 1/1/2016 forward) CLDI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLDI shares? During the previous two years, the following institutional investors and hedge funds held shares of Calidi Biotherapeutics shares: CPR Investments Inc. ($116K), Spectrum Asset Management Inc. NB CA ($94K), Apollo Management Holdings L.P. ($71K), Red Wave Investments LLC ($53K), RS Crum Inc. ($53K), Delta Investment Management LLC ($42K), and Magnetar Financial LLC ($36K).Learn more on CLDI's institutional investors. What percentage of Calidi Biotherapeutics stock is owned by institutional investors? 12.53% of Calidi Biotherapeutics stock is owned by institutional investors. Learn more on CLDI's institutional investor holdings. Which institutional investors have been buying Calidi Biotherapeutics stock? The following institutional investors have purchased Calidi Biotherapeutics stock in the last 24 months: CPR Investments Inc. ($535K), RS Crum Inc. ($252.62K), Delta Investment Management LLC ($200K), Spectrum Asset Management Inc. NB CA ($166.49K), Apollo Management Holdings L.P. ($125K), Evermay Wealth Management LLC ($63.42K), and Magnetar Financial LLC ($63.13K). How much institutional buying is happening at Calidi Biotherapeutics? Institutional investors have bought a total of 1,405,658 shares in the last 24 months. This purchase volume represents approximately $51.75K in transactions. Which Calidi Biotherapeutics major shareholders have been selling company stock? The following institutional investors have sold Calidi Biotherapeutics stock in the last 24 months: Red Wave Investments LLC ($578.14K). How much institutional selling is happening at Calidi Biotherapeutics? Institutional investors have sold a total of 578,141 shares in the last 24 months. This volume of shares sold represents approximately $659.08K in transactions. Related Companies Xilio Therapeutics Institutional Ownership VYNE Therapeutics Institutional Ownership Kezar Life Sciences Institutional Ownership Celularity Institutional Ownership Aileron Therapeutics Institutional Ownership Iterum Therapeutics Institutional Ownership Precision BioSciences Institutional Ownership SCYNEXIS Institutional Ownership Estrella Immunopharma Institutional Ownership vTv Therapeutics Institutional Ownership This page (NYSE:CLDI) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTexas embraces new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calidi Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
